Open competition
Open procedure: the contract was advertised and any supplier could submit a bid.
Key facts
- Buyer
- The NHS Commissioning Board (operating under the name of NHS England) · Ministry or any other national or federal authority, including their regional or local subdivisions
- Suppliers
- Accord-UK Ltd, Novartis Pharmaceuticals UK Ltd, Thornton and Ross Ltd, Zentiva Pharma UK Ltd, AstraZeneca, Cipla (EU) Ltd SME, Dr.Reddy's Laboratories (UK) Limited SME, Janssen-Cilag Ltd SME, Sandoz Ltd SME, Teva UK Limited
- Value
- £10 across 10 lots
- Procedure
- Open procedure
- Sector
- Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
- Region
- North West
- Official notice
- 004316-2021 on Find a Tender
- Timeline
-
- Contract date15 Jan 2021
- Published4 Mar 2021Published 48 days after the contract date
Description
Project title: invitation to offer for NHS National Pharmaceuticals – Fulvestrant, Darunavir and Imatinib Offer reference number: CM/PHG/20/5627Period of framework agreement: start date to be confirmed with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement: Fulvestrant: All regions: to commence as soon as possible with an end date of 1 May 2021 Darunavir: CESW Region: to commence as soon as possible with an end date of 1 May 2021 Imatinib: All regions: to commence as soon as possible with an end date of 31 October 2021. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.
Lots in this award
| Lot | Supplier | Value |
|---|---|---|
| NHS National Pharmaceuticals — Fulvestrant, Darunavir and Imatinib | Accord-UK Ltd | £1 |
| NHS National Pharmaceuticals — Fulvestrant, Darunavir and Imatinib | Novartis Pharmaceuticals UK Ltd | £1 |
| NHS National Pharmaceuticals — Fulvestrant, Darunavir and Imatinib | Thornton and Ross Ltd | £1 |
| NHS National Pharmaceuticals — Fulvestrant, Darunavir and Imatinib | Zentiva Pharma UK Ltd | £1 |
| NHS National Pharmaceuticals — Fulvestrant, Darunavir and Imatinib | AstraZeneca | £1 |
| NHS National Pharmaceuticals — Fulvestrant, Darunavir and Imatinib | Cipla (EU) Ltd SME | £1 |
| NHS National Pharmaceuticals — Fulvestrant, Darunavir and Imatinib | Dr.Reddy's Laboratories (UK) Limited SME | £1 |
| NHS National Pharmaceuticals — Fulvestrant, Darunavir and Imatinib | Janssen-Cilag Ltd SME | £1 |
| NHS National Pharmaceuticals — Fulvestrant, Darunavir and Imatinib | Sandoz Ltd SME | £1 |
| NHS National Pharmaceuticals — Fulvestrant, Darunavir and Imatinib | Teva UK Limited | £1 |
About the suppliers
Accord-UK Ltd: every public contract they have won.
Thornton and Ross Ltd: every public contract they have won, plus their Companies House record (company 00185947).
Zentiva Pharma UK Ltd: every public contract they have won.
AstraZeneca: every public contract they have won, plus their Companies House record (company 03674842).
Cipla (EU) Ltd: every public contract they have won.
Dr.Reddy's Laboratories (UK) Limited: every public contract they have won.
Janssen-Cilag Ltd: every public contract they have won.
Sandoz Ltd: every public contract they have won, plus their Companies House record (company 01547204).
Teva UK Limited: every public contract they have won, plus their Companies House record (company 00302461).
Novartis Pharmaceuticals UK Ltd: every public contract they have won.